NCT00119873View on ClinicalTrials.gov

Safety of and Immune Response to an Experimental HIV Vaccine (VRC-HIVADV014-00-VP) in HIV Uninfected Adults

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

Not specified

Study Completion Date

October 31, 2006

Conditions

HIV Infections

Interventions

BIOLOGICAL

VRC-HIVADV014-00-VP

Trial Locations (3)

37232

Vanderbilt Vaccine CRS, Nashville

98104

FHCRC/UW Vaccine CRS, Seattle

Unknown

San Francisco Vaccine and Prevention CRS, San Francisco

All Listed Sponsors

lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00119873 - Safety of and Immune Response to an Experimental HIV Vaccine (VRC-HIVADV014-00-VP) in HIV Uninfected Adults | Biotech Hunter | Biotech Hunter